2 hours ago
Updated Aug 04, 2026, 7:53 am EDT / Original Aug 04, 2026, 1:30 am EDT
A possible tie-up between Bristol Myers Squibb
BMY
-3.43%
and AstraZeneca might seem like a long shot to Wall Street skeptics, but the market’s enthusiasm around a potential deal points toward a broader trend that can’t be ignored.
BMY
-3.43%
Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
#updated #original #myers #wall
A possible tie-up between Bristol Myers Squibb
BMY
-3.43%
and AstraZeneca might seem like a long shot to Wall Street skeptics, but the market’s enthusiasm around a potential deal points toward a broader trend that can’t be ignored.
BMY
-3.43%
Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
#updated #original #myers #wall
1 day ago
Palantir Technologies (PLTR) topped Wall Street's second-quarter earnings and revenue targets as demand for its artificial intelligence software fueled a 12th straight quarter of accelerating revenue growth. Palantir stock surged on Tuesday as U.S. commercial growth also reaccelerated.
On the stock market today, Palantir stock surged nearly 30% to 162.67 in midday trading. With Tuesday's gain, Palantir erased much of its loss so far in 2026. And, Palantir stock climbed above its 200-day moving average, a key technical level.
Also, Tuesday's rally puts the stock on pace for its second-best daily performance since its initial public offering in September 2020, noted Bespoke Investment. The largest one-day gain for Palantir stock was over 30% on Feb. 6 2024 following an earnings report.
The data ****** ytics software maker reported Q2 results after the market close on Monday. For 2026, Palantir hiked its revenue outlook to a range of $8.150 billion to $8.158 billion. That was up from earlier guidance of $7.650 billion to $7.662 billion.
Further, Palantir raised 2026 guidance for revenue, adjusted operating income, and free cash flow. And, Palantir hiked U.S. commercial sales growth guidance from 120% to 134%.
#Stock #Growth #quarter
On the stock market today, Palantir stock surged nearly 30% to 162.67 in midday trading. With Tuesday's gain, Palantir erased much of its loss so far in 2026. And, Palantir stock climbed above its 200-day moving average, a key technical level.
Also, Tuesday's rally puts the stock on pace for its second-best daily performance since its initial public offering in September 2020, noted Bespoke Investment. The largest one-day gain for Palantir stock was over 30% on Feb. 6 2024 following an earnings report.
The data ****** ytics software maker reported Q2 results after the market close on Monday. For 2026, Palantir hiked its revenue outlook to a range of $8.150 billion to $8.158 billion. That was up from earlier guidance of $7.650 billion to $7.662 billion.
Further, Palantir raised 2026 guidance for revenue, adjusted operating income, and free cash flow. And, Palantir hiked U.S. commercial sales growth guidance from 120% to 134%.
#Stock #Growth #quarter
